![]() |
市场调查报告书
商品编码
1989058
互联家庭健康市场预测至2034年-按产品类型、类别、组件、应用、最终用户和地区分類的全球分析Connected Home Health Market Forecasts to 2034 - Global Analysis By Product Type, Type, Component, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2026 年,全球互联家庭健康市场规模将达到 4,559 亿美元,并在预测期内以 1.6% 的复合年增长率增长,到 2034 年将达到 5,206 亿美元。
互联家庭健康是一个整合了物联网医疗设备、人工智慧远端监测平台、远端医疗应用和数位健康管理服务的生态系统,旨在将以往在传统医疗机构开展的临床级健康监测、慢性病管理和预防性健康促进服务扩展到家庭环境中。这些解决方案包括远端患者监护设备、智慧生命征象监测仪、连网药物管理系统、人工智慧驱动的健康中心、虚拟护理平台和智慧跌倒侦测系统。它们透过云端的互通性框架与医疗服务提供者持续通信,满足慢性疾病患者。
对个人化家庭监控的需求
在消费者对根据个人生理基准、慢性病状况和生活方式量身定制的医疗保健体验的需求日益增长的推动下,设备製造商、远端医疗平台和医疗保健系统被迫投资于能够提供真正个性化监测和干预的互联家庭健康解决方案。人工智慧驱动的分析平台能够解读长期家庭生物特征数据,从而预测健康状况恶化、个人化药物依从性提醒,并根据个人反应模式调整护理通讯协定,这正在将互联家庭健康从被动的数据收集转变为主动的、个性化的健康管理。
医疗资料网路安全义务正在不断扩大。
互联家庭健康平台持续产生高度敏感的个人健康数据,包括生命征象、用药依从性、睡眠模式、活动数据以及慢性病生物标誌物,这给隐私、网路安全和合规性带来了重大挑战。美国部署的平台需遵守 HIPAA 法规,欧洲部署的平台需遵守 GDPR 法规,亚太地区各国还需遵守国家健康数据主权法规,这些法规都要求平台遵守复杂的合规体系,且因司法管辖区而异,从而显着增加了平台的开发和运营成本。
老年人辅助设备市场正在迅速扩张。
旨在帮助行动不便的老年人、慢性神经系统疾病患者、认知障碍患者的看护者以及缺乏附近医疗资源的农村和欠发达地区的居民的互联家庭健康技术,代表着一个快速增长且极具价值的商业机会。语音控制的医疗介面、人工智慧跌倒侦测系统、远端用药平台以及专为技术知识有限的用户设计的智慧生命体征监测器,正在为此前被排除在数位医疗应用之外的人群打开大门。
这家消费科技巨头在医疗保健领域占据主导地位
苹果、亚马逊、Google、三星和微软正积极拓展其互联健康生态系统,透过推出设备、投资健康数据平台以及与医疗服务提供者合作,充分利用其现有的消费设备渗透率和品牌信誉。这种扩张规模是任何一家互联家庭健康公司都无法比拟的。 Apple Health、Amazon Care、Google Health 和 Samsung Health 等平台能够产生强大的数据聚合和生态系统锁定效应,使这些科技巨头在互联家庭健康领域获得无与伦比的长期价值。获取消费者行为数据、庞大的应用分发网路以及将健康监测功能整合到现有设备类别中的能力,构成了它们不对称的竞争优势。
新冠疫情加速了远端医疗,展现了远端患者监护在急诊家庭健康领域的临床有效性,并加速了居家诊断和虚拟医疗服务的监管核准。医院容量的压力促使医疗系统迅速部署出院后病患的远距监测计画。疫情后,消费者的就医行为已永久转向居家监测,而疫情期间建立的远距远端医疗报销机制的扩展,为该领域的持续增长提供了强大的商业性基础。
在预测期内,远端患者监护(RPM)设备领域预计将占据最大的市场份额。
由于远端患者监护(RPM) 设备在为糖尿病、心臟衰竭、高血压和慢性阻塞性肺病 (COPD) 等慢性病高风险患者群体提供传统医疗机构之外的持续性、医生监督的健康监测方面发挥着至关重要的心臟衰竭,预计在预测期内,RPM 设备细分市场将占据最大的市场份额。美国医疗保险和医疗补助服务中心 (CMS) 扩大了远距生理监测的报销范围,加上医疗系统对居家医院和早期出院计画的投入不断增加,医疗服务提供者的采购需求显着增长。广泛的临床适应症、完善的设备认证流程以及健康保险公司对 RPM 计画的大力支持,共同促成了该细分市场的主导地位。
预计在预测期内,物联网(IoMT)领域将呈现最高的复合年增长率。
在预测期内,物联网 (IoMT) 领域预计将呈现最高的成长率,这主要得益于连网医疗设备部署的快速成长、基于云端的医疗数据整合基础设施以及人工智慧驱动的临床决策支援系统的普及。这些因素共同将把分散的健康监测资料流转化为一个连续的、可互通的医疗智慧网路。 IoMT 连接组件成本的降低、5G 网路覆盖范围的扩大(从而实现可靠的即时健康数据传输)以及电子健康记录 (EHR)互通性标准的不断完善,正在加速 IoMT 平台在全球医院系统、居家医疗和消费者健康市场的应用,并推动所有主要地区实现高于平均水平的增长。
在整个预测期内,北美预计将保持最大的市场份额。这主要得益于高度发展的远距远端医疗报销体系、消费者对穿戴式健康监测设备的广泛接受,以及大规模的慢性疾病患者和老年人口对远距医疗解决方案的结构性需求。美国在远端患者监护领域处于领先地位,其医疗保险和医疗服务中心 (CMS) 的报销代码、医疗保健系统对家庭护理项目的大力投资以及成熟的数位健康创业生态系统都功不可没。消费者在医疗保健技术方面的高支出以及连网监测设备保险覆盖范围的扩大,进一步巩固了该地区的领先地位。
在预测期内,亚太地区预计将呈现最高的复合年增长率。这主要得益于日本、中国、韩国和澳洲人口的快速老化,行动网路基础设施的扩展使得远端监测连接成为可能,以及各国政府对智慧医疗和居家养老计画的投入不断增加。印度远端医疗的快速普及、中国网路医院的扩张以及东南亚行动医疗的发展,都为互联居家医疗的普及创造了大规模的环境。中产阶级医疗费用支出的成长以及保险公司对预防性监测解决方案投入的增加,也进一步加速了该地区的成长。
According to Stratistics MRC, the Global Connected Home Health Market is accounted for $455.9 billion in 2026 and is expected to reach $520.6 billion by 2034 growing at a CAGR of 1.6% during the forecast period. Connected home health is an integrated ecosystem of IoT-enabled medical devices, AI-powered remote monitoring platforms, telehealth applications, and digital health management services that collectively extend clinical-grade health monitoring, chronic disease management, and preventive wellness capabilities from traditional healthcare facilities into the home environment. These solutions include remote patient monitoring devices, smart vital sign monitors, connected medication management systems, AI-driven health hubs, virtual care platforms, and smart fall detection systems that communicate continuously with healthcare providers through cloud-based interoperability frameworks, serving chronically ill patients, post-surgical recovery cases, aging individuals, maternal and infant health cases, and preventive wellness consumers.
Personalized Home Monitoring Demand
Escalating consumer demand for healthcare experiences tailored to individual physiological baselines, chronic disease profiles, and lifestyle patterns is compelling device manufacturers, telehealth platforms, and health systems to invest in connected home health solutions that deliver genuinely personalized monitoring and intervention. AI-powered analytics platforms capable of interpreting longitudinal home biometric data to predict deterioration events, personalize medication adherence nudges, and adapt care protocols to individual response patterns are transforming connected home health from passive data collection into active, individualized health managements
Health Data Cybersecurity Obligations Escalate
Connected home health platforms generate continuous streams of highly sensitive personal health data including vital signs, medication adherence, sleep patterns, mobility data, and chronic disease biomarkers, creating substantial privacy, cybersecurity, and regulatory compliance obligations. HIPAA requirements for US-deployed platforms, GDPR for European deployments, and national health data sovereignty regulations across Asia Pacific impose complex, jurisdiction-specific compliance architectures that significantly increase platform development and operational costs.
Elderly Assistive Care Devices Rapidly Expanding
Connected home health technologies designed to assist elderly individuals with limited mobility, patients with chronic neurological conditions, caregivers of individuals with cognitive impairment, and populations in rural or underserved communities lacking proximate healthcare access represent a rapidly expanding high-value opportunity. Voice-controlled health interfaces, AI fall detection systems, remote medication dispensing platforms, and smart vital sign monitors configured for users with limited technical literacy are unlocking demographic segments previously excluded from digital health adoption.
Consumer Tech Giants Dominate Health
Apple, Amazon, Google, Samsung, and Microsoft are aggressively expanding their connected health ecosystems through device launches, health data platform investments, and healthcare provider partnerships that leverage existing consumer device footprints and brand trust at a scale specialist connected home health companies cannot replicate. Apple Health, Amazon Care, Google Health, and Samsung Health platforms create powerful data aggregation and ecosystem lock-in effects that position these technology giants to capture disproportionate long-term connected home health value. Their access to consumer behavioral data, dominant app distribution channels, and ability to bundle health monitoring within existing device categories creates asymmetric competitive advantages.
The COVID-19 pandemic catalyzed transformational growth in connected home health by driving mass adoption of telehealth, demonstrating the clinical viability of remote patient monitoring for acute and chronic care management, and accelerating regulatory acceptance of home-based diagnostics and virtual care delivery. Hospital capacity pressures incentivized health systems to rapidly deploy remote monitoring programs for post-discharge patients. Post-pandemic health consumer behavior has permanently shifted toward home-based monitoring preferences, and expanded telehealth reimbursement frameworks established during the pandemic provide durable commercial infrastructure supporting sustained sector growth.
The remote patient monitoring (RPM) devices segment is expected to be the largest during the forecast period
The remote patient monitoring (RPM) devices segment is expected to account for the largest market share during the forecast period, due to the critical role these devices play in enabling continuous, clinician-supervised health surveillance outside of traditional care settings for high-risk patient populations managing chronic conditions including diabetes, heart failure, hypertension, and COPD. CMS reimbursement code expansion for remote physiological monitoring in the United States, combined with growing health system investment in hospital-at-home and early discharge programs, has created substantial institutional procurement demand. The breadth of clinical indications served, established device certification pathways, and strong health insurer support for RPM programs collectively underpin this segment's dominant market position.
The internet of medical things (IoMT) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the internet of medical things (IoMT) segment segment is predicted to witness the highest growth rate, driven by exponential growth of connected medical device deployments, cloud health data integration infrastructure, and AI-powered clinical decision support systems that collectively transform discrete health monitoring data streams into continuous, interoperable care intelligence networks. Falling IoMT connectivity component costs, expanding 5G network coverage enabling reliable real-time health data transmission, and deepening electronic health record interoperability standards are accelerating IoMT platform adoption across hospital systems, home health agencies, and consumer wellness markets globally, driving above-average growth across all key geographies.
During the forecast period, the North America region is expected to hold the largest market share, underpinned by a highly developed telehealth reimbursement landscape, widespread consumer adoption of wearable health monitoring devices, and a large chronically ill and aging population creating structural demand for remote care solutions. The United States leads with CMS remote patient monitoring reimbursement codes, strong health system investment in hospital-at-home programs, and a mature digital health venture ecosystem. High consumer health technology spending and growing insurer coverage of connected monitoring devices reinforce the region's dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly aging populations in Japan, China, South Korea, and Australia, expanding mobile internet infrastructure enabling remote monitoring connectivity, and growing government investment in smart healthcare and aging-in-place programs. India's telemedicine adoption surge, China's internet hospital expansion, and Southeast Asia's mobile health growth are creating large-scale connected home health deployment environments. Rising middle-class health spending and growing insurer investment in preventive monitoring solutions amplify the region's growth momentum.
Key players in the market
Some of the key players in Connected Home Health Market include Philips Healthcare, Medtronic plc, Abbott Laboratories, Omron Healthcare Co., Ltd., Fitbit, Apple Inc., Samsung Electronics Co., Ltd., Withings S.A., ResMed Inc., Dexcom Inc., iRhythm Technologies Inc., BioTelemetry Inc., Teladoc Health Inc., Amazon Care, Best Buy Health, Honeywell Life Care Solutions, GE HealthCare Technologies Inc., and Garmin Ltd.
In February 2026, Philips announced advancements in its remote patient monitoring solutions, integrating AI-driven analytics into home health devices. This update enhances early detection of chronic condition risks and supports its goal of improving the lives of 2.5 billion people annually by 2030.
In January 2026, Medtronic introduced new AI-powered diagnostic features in its connected care devices, including pulse oximeters and monitoring systems. These innovations allow real-time detection of cardiovascular and gastrointestinal conditions, strengthening its role in home-based preventive care.
In December 2025, Samsung showcased its expanded Samsung Health ecosystem, integrating virtual care, prescription management, and clinical data through its acquisition of Xealth. This move connects wellness tracking with healthcare delivery, positioning Samsung as a key player in connected home health.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.